SynthesisBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2026

Ustekinumab Biosimilars versus Reference Ustekinumab for Moderate-to-Severe Plaque Psoriasis: A Pre-switch Systematic Review and Meta-analysis.

Carlos Roberto Montes-de-Oca-Saucedo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.